
Opinion|Videos|January 17, 2025
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Author(s)Jeff Hall
In the second part of a two-part interview on the recently published appropriate use criteria for brain positron emission tomography (PET) for patients with mild cognitive impairment (MCI), Phillip Kuo, M.D. discusses clinical cases involving the use of amyloid and tau PET imaging.
Advertisement
Advertisement
“I like to say that amyloid (PET) is necessary for the diagnosis of Alzheimer’s disease but not sufficient,” noted Phillip Kuo, M.D., during a recent interview to discuss the recently released appropriate use criteria for amyloid and tau positron emission tomography (PET) in patients with mild cognitive impairment (MCI).
Related to this article

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the evolution, research and pearls for ablation procedures, and emerging considerations for histotripsy in the realm of interventional oncology.

Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.

The AI-powered NeuroDR software reportedly removes bone, soft tissue and veins from CTA scans and provides subsequent 3D MIP views and curved planar reformatted views of carotid and vertebral arteries.

The newly cleared Aview Aorta Metrics software reportedly offers automated segmentation of aortic regions and classification of aortic zones based on chest CT images.

Facilitating enhanced 3D visualization of skeletal anatomy, the BoneEnhance machine learning module reportedly provides automated segmentation of bone and surrounding tissues for the Accuro XV ultrasound system.

Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
Advertisement
Advertisement


